资讯

Yahoo Finance23 天
ABIONYX Pharma: Availability of the Universal Registration Document for the Year 2024
TOULOUSE, France & LAKELAND, Mich., March 17, 2025--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma (FR0012616852 - ABNX - PEA PME eligible), a next generation biopharma company dedicated to the ...
Business Wire19 天
CIC Market Solutions Initiates Buy Coverage of ABIONYX Pharma
TOULOUSE, France & LAKELAND, Mich.--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma (FR0012616852 - ABNX - PEA PME eligible), next-generation biopharma dedicated to the development of innovative ...
Yahoo Finance19 天
CIC Market Solutions Initiates Buy Coverage of ABIONYX Pharma
TOULOUSE, France & LAKELAND, Mich., March 21, 2025--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma (FR0012616852 - ABNX - PEA PME eligible), next-generation ...
Business Wire1 个月
2023
TOULOUSE, France & LAKELAND, Mich.--(BUSINESS WIRE)--Regulatory News: ABIONYX Pharma, (FR0012616852 - ABNX - eligible for PEA PME), a next generation biopharma company dedicated to the development ...
Morningstar1 个月
World Rare Disease Day: ABIONYX renews its commitment to treat LCAT Deficiency (Norum's ...
ABIONYX Pharma, (FR0012616852 - ABNX - eligible for PEA PME), a next generation biopharma company dedicated to the development of innovative biomedicines based on a recombinant apolipoprotein apoA ...